RPT-GCN2i

N/A

Report date: 2024/11/18 13:25:57
NME

Base Information

Drug NameRPT-GCN2i
Drug Alias NameRPT-GCN2i
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterferon-induced, double-stranded RNA-activated protein kinase inhibitors
TargetsInterferon-induced, double-stranded RNA-activated protein kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRapt Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRapt Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A